Activated cMET and IGF1R-Driven PI3K Signaling Predicts Poor Survival in Colorectal Cancers Independent of KRAS Mutational Status

BACKGROUND: Oncogenic mutational analysis provides predictive guidance for therapeutics such as anti-EGFR antibodies, but it is successful only for a subset of colorectal cancer (CRC) patients. METHOD: A comprehensive molecular profiling of 120 CRC patients, including 116 primary, 15 liver metastasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jeeyun, Jain, Anjali, Kim, Phillip, Lee, Tani, Kuller, Anne, Princen, Fred, In-Gu, Kim, Suk Hyeong, Park, Joon Oh, Park, Young Suk, Singh, Sharat, Kim, Hee Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121133/
https://www.ncbi.nlm.nih.gov/pubmed/25090459
http://dx.doi.org/10.1371/journal.pone.0103551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121133/
https://www.ncbi.nlm.nih.gov/pubmed/25090459
http://dx.doi.org/10.1371/journal.pone.0103551

Ejemplares similares